12:55 EDT Nuvation Bio (NUVB) trading halted, news pending
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUVB:
- FDA announces apporval of Nuvation Bio’s Ibtrozi for lung cancer
- Nuvation kinase inhibitor wins FDA approval in non-small cell lung cancer
- Nuvation Bio jumps 4% to $2.64 after FDA approves Ibtrozi
- Nuvation Bio’s Strategic Positioning and Potential FDA Approval: Analyst Recommends Buy Rating
- Nuvation Bio Holds Successful Annual Meeting 2025